| 24 |
THE SELECTION AND USE OF REFERENCE MATERIALS |
2003-02-25 |
| 23 |
DETECTION OF RESIDUAL PENICILLINS IN DRUGS |
2003-02-25 |
| 22 |
Risk-Based Approach to 21 CFR Part 11 |
2003-02-24 |
| 21 |
Pharmaceutical cGMPs for the 21st Century |
2003-02-23 |
| 20 |
Pharmaceutical cGMP Initiative Questions and Answe |
2003-01-25 |
| 19 |
An Overview of the FDA’s PAT Initiative |
2003-01-23 |
| 18 |
How to Approach FDA Validation |
2003-01-22 |
| 17 |
KGMP 해설서- 정오표 |
2002-12-03 |
| 16 |
Guidance_Bioavailability_Bioequivalence |
2002-08-25 |
| 15 |
Development of Analytical Methods |
2002-08-24 |
